Latest News
GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline
25 February 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) revealed on Wednesday that it has agreed to acquire 35Pharma Inc., a Canada-based clinical-stage biopharmaceutical company, for USD950m in cash, expanding its respiratory and...
SoftOx secures Irish approval for Phase 1 trial of SIS-02
25 February 2026 - SoftOx Defense Solutions AS, a subsidiary of clinical-stage pharmaceutical company SoftOx Solutions AS (Euronext Growth Oslo:SOFTX), announced on Wednesday that Ireland's Health Products Regulatory Authority has approved its c...
Avid Bioservices opens new Early Phase Center of Excellence
25 February 2026 - Avid Bioservices Inc, a biologics contract development and manufacturing organization (CDMO), announced on Tuesday the opening of its new Early Phase Center of Excellence in Costa Mesa, California.The 78,000 sq ft facility is purpo...
OrthoTrophix completes patient enrolment in TPX-100 Phase 2b clinical trial
25 February 2026 - US biopharmaceutical company OrthoTrophix Inc announced on Tuesday the early completion of the planned patient enrolment in its Phase 2b clinical trial of intra-articular TPX-100 for the treatment of knee osteoarthritis (OA).The mu...
Bloom Science doses first patient in Phase 1b trial of BL-001 for obesity treatment
25 February 2026 - Clinical-stage biotech company Bloom Science Inc announced on Tuesday that the first patient has been dosed in its Phase 1b clinical trial evaluating BL-001 in adults with obesity.The randomised, double-blind, placebo-controlled tr...